These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 15037022)
1. Alzheimer's Abeta vaccination of rhesus monkeys (Macaca mulatta). Gandy S; DeMattos RB; Lemere CA; Heppner FL; Leverone J; Aguzzi A; Ershler WB; Dai J; Fraser P; St George Hyslop P; Holtzman DM; Walker LC; Keller ET Mech Ageing Dev; 2004 Feb; 125(2):149-51. PubMed ID: 15037022 [TBL] [Abstract][Full Text] [Related]
2. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine. Li SB; Wang HQ; Lin X; Xu J; Xie Y; Yuan QF; Yao ZB Chin Med J (Engl); 2005 Apr; 118(8):660-4. PubMed ID: 15899121 [TBL] [Abstract][Full Text] [Related]
3. Active immunization trial in Abeta42-injected P301L tau transgenic mice. Kulic L; Kurosinski P; Chen F; Tracy J; Mohajeri MH; Li H; Nitsch RM; Götz J Neurobiol Dis; 2006 Apr; 22(1):50-6. PubMed ID: 16289870 [TBL] [Abstract][Full Text] [Related]
5. [Specific humoral immune response in Rhesus monkeys vaccinated immune response with Abeta42 peptide vaccine]. Li SB; Wang HQ; Lin X; Xu J; Yao ZB Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):202-4. PubMed ID: 15766406 [TBL] [Abstract][Full Text] [Related]
6. Assessment of non-viral amyloid-β DNA vaccines on amyloid-β reduction and safety in rhesus monkeys. Tokita Y; Kaji K; Lu J; Okura Y; Kohyama K; Matsumoto Y J Alzheimers Dis; 2010; 22(4):1351-61. PubMed ID: 20930304 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies. Geylis V; Steinitz M Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209 [TBL] [Abstract][Full Text] [Related]
8. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056 [TBL] [Abstract][Full Text] [Related]
9. Anti-Abeta: The good, the bad, and the unforeseen. Broytman O; Malter JS J Neurosci Res; 2004 Feb; 75(3):301-6. PubMed ID: 14743443 [TBL] [Abstract][Full Text] [Related]
10. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Jensen MT; Mottin MD; Cracchiolo JR; Leighty RE; Arendash GW Neuroscience; 2005; 130(3):667-84. PubMed ID: 15590151 [TBL] [Abstract][Full Text] [Related]
11. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model. Matsuda J; Kaminaka K; Nozaki C Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678 [TBL] [Abstract][Full Text] [Related]
12. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Mruthinti S; Buccafusco JJ; Hill WD; Waller JL; Jackson TW; Zamrini EY; Schade RF Neurobiol Aging; 2004 Sep; 25(8):1023-32. PubMed ID: 15212827 [TBL] [Abstract][Full Text] [Related]
13. Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies. Lee M; Bard F; Johnson-Wood K; Lee C; Hu K; Griffith SG; Black RS; Schenk D; Seubert P Ann Neurol; 2005 Sep; 58(3):430-5. PubMed ID: 16130106 [TBL] [Abstract][Full Text] [Related]
14. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response. Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202 [TBL] [Abstract][Full Text] [Related]
15. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease. Kim HD; Maxwell JA; Kong FK; Tang DC; Fukuchi K Biochem Biophys Res Commun; 2005 Oct; 336(1):84-92. PubMed ID: 16126169 [TBL] [Abstract][Full Text] [Related]
16. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease. Wang CY; Finstad CL; Walfield AM; Sia C; Sokoll KK; Chang TY; Fang XD; Hung CH; Hutter-Paier B; Windisch M Vaccine; 2007 Apr; 25(16):3041-52. PubMed ID: 17287052 [TBL] [Abstract][Full Text] [Related]